Section one: Contracting authority
one.1) Name and addresses
Health Innovation North East and North Cumbria
Suite A, 2nd Floor, 1 Citygate, Gallowgate
Newcastle-upon-Tyne
NE1 4WH
BusinessDevelopment@healthinnovationnenc.org.uk
Telephone
+44 1916076350
Country
United Kingdom
Region code
UK - United Kingdom
Internet address(es)
Main address
https://healthinnovationnenc.org.uk/
Buyer's address
https://healthinnovationnenc.org.uk/
one.4) Type of the contracting authority
Other type
CLG
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
National Child Parent Screening Service Evaluation
Reference number
DN736345
two.1.2) Main CPV code
- 79419000 - Evaluation consultancy services
two.1.3) Type of contract
Services
two.1.4) Short description
Funding was received by Health Innovation North East and North Cumbria (HI NENC) in April 2021 to implement and lead on the national Child Parent Screening Programme. This was in order to support the ambition set out in the NHS Long Term Plan to improve the identification of Familial Hypercholesterolaemia (FH) to 25% by 2025.
Previously, HI NENC had embarked on a programme of work to search primary care records for those at risk of FH. Alone this was unlikely to achieve the NHS LTP ambition - the addition of a child-parent screening (CPS) programme was introduced to help increase identification of FH patients and their families.
FH, an autosomal dominant inherited disorder, is a common cause of ischaemic cardiovascular disease in young adult life. There are about 200,000 undiagnosed people with FH in the UK. Identifying affected individuals before the onset of disease is important so diet and lifestyle modifications can be made and medication initiated as appropriate.
As each affected child will have one affected parent, testing children provides a means of identifying and treating both child and parent together in a systematic manner.
This project aims to evaluate the effectiveness of the implementation of the child parent screening service as well as the impact it has had. A mixed methods approach will be used drawing on a variety of techniques.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £39,850
two.2) Description
two.2.2) Additional CPV code(s)
- 73000000 - Research and development services and related consultancy services
- 79419000 - Evaluation consultancy services
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
Funding was received by Health Innovation North East and North Cumbria (HI NENC) in April 2021 to implement and lead on the national Child Parent Screening Programme. This was in order to support the ambition set out in the NHS Long Term Plan to improve the identification of Familial Hypercholesterolaemia (FH) to 25% by 2025.
Previously, HI NENC had embarked on a programme of work to search primary care records for those at risk of FH. Alone this was unlikely to achieve the NHS LTP ambition - the addition of a child-parent screening (CPS) programme was introduced to help increase identification of FH patients and their families.
FH, an autosomal dominant inherited disorder, is a common cause of ischaemic cardiovascular disease in young adult life. There are about 200,000 undiagnosed people with FH in the UK. Identifying affected individuals before the onset of disease is important so diet and lifestyle modifications can be made and medication initiated as appropriate.
As each affected child will have one affected parent, testing children provides a means of identifying and treating both child and parent together in a systematic manner.
This project aims to evaluate the effectiveness of the implementation of the child parent screening service as well as the impact it has had. A mixed methods approach will be used drawing on a variety of techniques.
two.2.5) Award criteria
Quality criterion - Name: Technical/Quality / Weighting: 70
Quality criterion - Name: Social Value / Weighting: 10
Price - Weighting: 20
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Restricted procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2023/S 000-015073
Section five. Award of contract
Lot No
3
Title
National Child Parent Screening Service Evaluation
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
24 September 2024
five.2.2) Information about tenders
Number of tenders received: 4
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Health Innovation North East and North Cumbria
Suite A, 2nd Floor, 1 Citygate, Gallowgate
Newcastle-upon-Tyne
NE1 4WH
BusinessDevelopment@healthinnovationnenc.org.uk
Telephone
+44 1916076350
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £39,850
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
Health Innovation North East and North Cumbria
Newcastle-upon-Tyne
Country
United Kingdom